✦ LIBER ✦

A phase I, open-label, single-arm study for QT assessment of eribulin mesylate in patients with advanced solid tumors

✍ Scribed by Thierry Lesimple, Julien Edeline, Timothy J. Carrothers, Frédérique Cvitkovic, Borje Darpo, Jean-Pierre Delord, Hervé Léna, Nicolas Penel, Geoff J. Edwards, Kenneth Law, Jantien Wanders, Allan Kristensen, Larisa Reyderman…show all 13hide

Book ID: 120966744
Publisher: Springer US
Year: 2012
Tongue: English
Weight: 391 KB
Volume: 31
Category: Article
ISSN: 0167-6997
DOI: 10.1007/s10637-012-9893-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1244 POSTER An Open-Label, Multicenter,

1244 POSTER An Open-Label, Multicenter, Single Arm QT Interval Prolongation Study of Eribulin Mesylate in Patients With Advanced Solid Tumours

✍ J. Edeline; H. Lena; E.C. Cvitkovic; N. Penel; L. Reyderman; G. Edwards; K. Law; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

A Phase I, open-label, dose-escalation s

A Phase I, open-label, dose-escalation study of continuous once-daily oral treatment with afatinib in patients with advanced solid tumors

✍ Michael S. Gordon,David S. Mendelson,Mitchell Gross… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 200 KB

A Phase I, open-label, dose escalation s

A Phase I, open-label, dose escalation study of afatinib, in a 3-week-on/1-week-off schedule in patients with advanced solid tumors

✍ John Marshall,Jimmy Hwang,Ferry A. L. M. Eskens… 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 223 KB

Phase I Study of Copper-Binding Agent AT

Phase I Study of Copper-Binding Agent ATN-224 in Patients with Advanced Solid Tumors

✍ Lowndes, S. A.; Adams, A.; Timms, A.; Fisher, N.; Smythe, J.; Watt, S. M.; Joel, 📂 Article 📅 2008 🏛 American Association for Cancer Research 🌐 English ⚖ 326 KB

Phase I Dose-Escalation and Pharmacokine

Phase I Dose-Escalation and Pharmacokinetic Study of Dasatinib in Patients with Advanced Solid Tumors

✍ Demetri, G. D.; Lo Russo, P.; MacPherson, I. R.J.; Wang, D.; Morgan, J. A.; Brun 📂 Article 📅 2009 🏛 American Association for Cancer Research 🌐 English ⚖ 238 KB

Results of a phase I, open-label, random

Results of a phase I, open-label, randomized, crossover study evaluating the effects of linifanib on QTc intervals in patients with solid tumors

✍ Chiu, Yi-Lin; LoRusso, Patricia; Hosmane, Balakrishna; Ricker, Justin L.; Awni, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 287 KB